You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 24, 2024

Details for Patent: 7,312,237


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,312,237 protect, and when does it expire?

Patent 7,312,237 protects IXEMPRA KIT and is included in one NDA.

Protection for IXEMPRA KIT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-four patent family members in twenty-six countries.

Summary for Patent: 7,312,237
Title:Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolilferative diseases
Abstract:Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders.
Inventor(s): Lee; Francis Y. F. (Yardley, PA)
Assignee: Bristol-Myers Squibb Co. (Princeton, NJ)
Application Number:10/091,061
Patent Claim Types:
see list of patent claims
Use; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,312,237: A Comprehensive Analysis

Introduction

When delving into the world of patents, understanding the scope and claims of a specific patent is crucial for inventors, businesses, and legal professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 7,312,237, using relevant data and methodologies to contextualize its significance within the patent landscape.

Background on Patent 7,312,237

To begin, it is essential to identify the patent in question. However, since the specific details of Patent 7,312,237 are not provided in the query, we will use general principles and methodologies to analyze its scope and claims.

Patent Allowance Rates

Before diving into the specifics of a single patent, it is helpful to understand the broader context of patent allowance rates. Research indicates that only about 55.8% of patent applications filed at the U.S. Patent and Trademark Office (USPTO) are eventually granted without using continuation procedures[1].

Types of Patent Allowance Rates

There are several measures of patent allowance rates:

  • First-Action Allowance Rate: The proportion of progenitor applications allowed without further examination.
  • Progenitor Allowance Rate: The proportion of progenitor applications allowed without any continuation procedure.
  • Family Allowance Rate: The proportion of progenitor applications that produce at least one patent, including the outcomes of continuation applications[1].

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset includes claim-level statistics and document-level statistics, offering insights into the scope and complexity of patent claims[3].

Claim Structure

Patent claims typically follow a specific structure:

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the scope of an independent claim.

Claim Scope

The scope of a patent claim is critical in determining what is protected by the patent. Broader claims may offer more extensive protection but are also more likely to face challenges during the examination process. Narrower claims, while more specific, may provide stronger protection but limit the scope of the invention[3].

Analyzing the Patent Landscape

To analyze the patent landscape surrounding a specific patent like 7,312,237, one must consider several factors:

Technology Fields

Patents are often categorized into broad technology fields such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous “Other” category. The allowance rates and challenges faced can vary significantly across these fields[1].

Continuation Procedures

Continuation procedures, such as Requests for Continued Examination (RCEs), are common and can significantly impact the prosecution history of a patent application. These procedures allow applicants to continue pursuing a patent after an initial rejection, which can affect the final scope and claims of the patent[1].

Searching and Analyzing Patents

To conduct a thorough analysis of a patent, one can use various databases and tools provided by the USPTO and other organizations:

  • Patent Public Search: This tool from the USPTO allows for full-text searching of patent grants and applications from the United States and over 100 other patent offices worldwide[4].
  • Cooperative Patent Classification (CPC) Database: This database helps in finding relevant classification schemes, which can be crucial in understanding the technological context of a patent[4].

Case Study: Analyzing Patent 7,312,237

While specific details of Patent 7,312,237 are not available here, a typical analysis would involve:

  • Identifying the Technology Field: Determine the broad technology field in which the patent falls to understand the relevant market and competitive landscape.
  • Examining the Claims: Analyze the independent and dependent claims to understand the scope of the invention.
  • Reviewing Prosecution History: Use tools like the USPTO's PAIR system to review the prosecution history, including any continuation procedures, RCEs, and amendments made during the examination process[1].

Impact of Continuation Procedures

Continuation procedures can significantly affect the final scope and claims of a patent. For instance, if an applicant files multiple RCEs, it may indicate challenges in getting the patent approved, which could narrow the scope of the claims over time[1].

Legal and Business Implications

Understanding the scope and claims of a patent is crucial for both legal and business strategies:

  • Infringement Analysis: Knowing the exact scope of a patent helps in determining whether a product or process infringes on the patent.
  • Licensing and Litigation: The scope and claims can significantly impact licensing agreements and litigation strategies[3].

Key Takeaways

  • Patent Allowance Rates: Only about 55.8% of patent applications are granted without continuation procedures.
  • Claim Structure: Independent and dependent claims define the scope of the invention.
  • Technology Fields: Allowance rates and challenges vary across different technology fields.
  • Continuation Procedures: These can impact the final scope and claims of a patent.
  • Legal and Business Implications: Understanding the scope and claims is crucial for infringement analysis, licensing, and litigation.

FAQs

What is the typical allowance rate for patent applications at the USPTO?

The typical allowance rate for patent applications at the USPTO is about 55.8% without using continuation procedures[1].

How do continuation procedures affect the scope of a patent?

Continuation procedures, such as RCEs, can lead to amendments and narrowing of the claims, affecting the final scope of the patent[1].

What is the importance of understanding patent claims?

Understanding patent claims is crucial for determining the scope of the invention, which impacts infringement analysis, licensing agreements, and litigation strategies[3].

How can one search and analyze patents effectively?

Using tools like the USPTO's Patent Public Search, Cooperative Patent Classification (CPC) database, and reviewing prosecution histories through the PAIR system can help in effectively searching and analyzing patents[4].

What are the different types of patent allowance rates?

The different types include first-action allowance rate, progenitor allowance rate, and family allowance rate, each providing different insights into the patent examination process[1].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. United States Courts. Report on Filing Patent/Trademark.
  3. USPTO. Patent Claims Research Dataset.
  4. Clemson University Libraries. Research and Course Guides: Patent Searching, Advanced: Overview.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,312,237

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-001 Oct 16, 2007 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
R-pharm Us Llc IXEMPRA KIT ixabepilone INJECTABLE;INTRAVENOUS 022065-002 Oct 16, 2007 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.